Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
Darenzepine is a muscarinic receptor inhibitor which is useful for the treatment of CNS disorders[1].
[1]. Eric Elenko, et al. Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation. US 20170095465 A1.
















